Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;43(9):2755-2763.
doi: 10.1002/hed.26739. Epub 2021 May 17.

The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma

Khodayar Goshtasbi  1 , Arash Abiri  1 , Brandon M Lehrich  2 , Yarah M Haidar  1 , Tjoson Tjoa  1 , Edward C Kuan  1
Affiliations

The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma

Khodayar Goshtasbi et al. Head Neck. 2021 Sep.

Abstract

Background: This study evaluates the influence of facility case-volume on nasopharyngeal carcinoma (NPC) treatments and overall survival (OS).

Methods: The 2004-2015 National Cancer Database was queried for patients with NPC receiving definitive treatment.

Results: A total of 8260 patients (5-year OS: 63.4%) were included. The 1114 unique facilities were categorized into 854 low-volume (treating 1-8 patients), 200 intermediate-volume (treating 9-23 patients), and 60 high-volume (treating 24-187 patients) facilities. Kaplan-Meier log-rank analysis demonstrated significantly improved OS with high-volume facilities (p < 0.001). On cox proportional-hazard multivariate regression after adjusting for age, sex, income, insurance, comorbidity index, histology, AJCC clinical stage, and treatment type, high-volume facilities were associated with lower mortality risk than low-volume (HR = 0.865, p = 0.019) and intermediate-volume facilities (HR = 0.916, p = 0.004). Propensity score matching analysis confirmed this association (p < 0.001).

Conclusion: Higher facility volume was an independent predictor of improved OS in NPC, suggesting a possible survival benefit of referrals to high-volume medical centers.

Keywords: facility volume; hospital volume; nasopharyngeal carcinoma; outcomes; overall survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: ECK is a consultant for Stryker ENT (Kalamazoo, MI)

Figures

Figure 1.
Figure 1.
Flowchart of patient selection process.
Figure 2.
Figure 2.
Kaplan-Meier curves of overall survival in patients with nasopharyngeal carcinoma stratified by low-volume (1-8 patients treated per center, total n=2,909 patients), intermediate-volume (9-23 patients treated per center, total n=2,647 patients), and high-volume facility (24-187 patients treated per center, total n=2,704 patients) patients. The analysis demonstrated a statistically significant positive association between facility volume and OS (p<0.001). Shaded areas indicate 95% confidence intervals.
Figure 3.
Figure 3.
Kaplan-Meier (KM) curves of overall survival (OS) in patients with nasopharyngeal carcinoma (NPC) matched by their demographic and clinical factors, demonstrating significant improvement of OS with high facility volume. Figure (A) compares matched patients treated at low (n=1,550) and intermediate (n=1,550) volume facilities. Figure (B) compares matched patients treated at intermediate (n=1,550) and high (n=1,550) volume facilities. Figure (C) compares matched patients treated at low (n=1,601) and high (n=1,601) volume facilities. Shaded areas indicate 95% confidence intervals.
See this image and copyright information in PMC

References

    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
    1. PDQ. PDQ® - NCI's Comprehensive Database. National Cancer Institute; https://wwwcancergov/publications/pdq Accessed Dec 20, 2020.
    1. NCCN. National Comprehensive Cancer Network. https://www.nccn.org/. Accessed Dec 20, 2020.
    1. Colevas AD, Yom SS, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479–90. - PubMed
    1. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–54. - PubMed

Publication types